|
|
|
|
|
|
| Abstract Search | Browse Program and Abstracts | Schedule-at-a-Glance | Conference Mission & Sponsors | Program Committee | Contact Us |
| # | Title |
|---|---|
| 37 | Replication-Incompetent Recombinant Adenovirus Vector Expressing SIV gag Elicits Robust and Effective Cellular Immune Responses in Rhesus Macaques
T.-M. Fu, W. Trigona*, M.-E. Davies, Z.-Q. Zhang, D. Casimiro, S. Dubey, D. C. Freed, J. Joyce, K. Grimm, W. A. Schleif, N. L. Letvin, E. A. Emini, and J. W. Shiver Merck Res. Labs, West Point, PA, USA |
| 38 | An Effective AIDS Vaccine Based on Live-Attenuated Vesicular Stomatitis Virus Recombinants
N. Rose1, P. Marx2,3, A. Luckay3, D. Nixon4, W. Moretto4, S. Donahoe4, D. Montefiori5, A. Roberts1, and J. Rose*1 1Yale Univ. Sch. of Med., New Haven, CT, USA; 2Aaron Diamond AIDS Res. Ctr., New York, NY, USA; 3Tulane Reg. Primate Ctr., Covington, LA, USA; 4Gladstone Inst., San Francisco, CA, USA; and 5Duke Univ. Med. Ctr., Durham, NC, USA |
| 39 | Early Antiretroviral Treatment Facilitates CD8+ Lymphocyte-Mediated Control of Pathogenic SIV Infection and Resistance to Homologous and Heterologous Rechallenge
J. D. Lifson*1, J. L. Rossio1, M. Piatak, Jr.1, B. M. Flynn2, B. Fisher2, R. C. Desrosiers3, V. M. Hirsch4, K. Reimann5, J. Schmitz5, J. Ghrayeb6, N. Bischofberger7, D. Wodarz8, and M. A. Nowak8 1AVP, SAIC Frederick, NCI at Frederick, MD, USA; 2ASB/NCI, Bethesda, MD, USA; 3HMS/NERPRC, Southborough, MA, USA;4LMM/NIAID, Bethesda, MD, USA; 5HMS/BIMC, Boston, MA, USA; 6Centocor, Malvern, PA, USA; 7Gilead Sci., Foster City, CA, USA; and 8IAS, Princeton, NJ, USA |
| 40 | Durable Long-Term Immune Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Plasmid Cytokine-Augmented DNA Vaccination
D. H. Barouch*1, S. Santra1, J. E. Schmitz1, M. J. Kuroda1, W. Wagner2, J. Kunstman3, D. C. Montefiori4, S. M. Wolinsky3, M. G. Lewis2, and N. L. Letvin1 1BIDMC, Harvard Med. Sch., Boston, MA, USA; 2Southern Res. Inst., Frederick, MD, USA; 3Northwestern Univ., Chicago, IL, USA; and 4Duke Univ., Durham, NC, USA |
| 41 | Intrarectal Challenge of Macaques Immunized with VEE Replicon Vectors
R. Johnston*1, N. Davis1, M. Collier1, M. Connell2, A. Nielsen1, L. Hensley1, D. Montefiori3, R. Swanstrom1, J. Frelinger1, C. Walker2, and P. Johnson2 1Univ. of North Carolina, Chapel Hill, NC, USA; 2Children's Res. Inst., Columbus, OH, USA; and 3Duke Univ., Durham, NC, USA |
| 42 | Improved Efficacy of DNA Vaccination Using a New Generation of Optimized HIV and SIV Plasmids
G. N. Pavlakis1, M. Rosati1, P. Eyler1, A. Valentin1, H. Trivedi1, A. Biragyn1, L. W. Kwak1, P. Markham2, R. Woodward 2, A. von Gegerfelt1, N. Miller3, and B. K. Felber1 1NCI at Frederick, MD, USA; 2Advanced BioScience Labs, Inc., Kensington, MD, USA; and 3NIAID, NIH, Bethesda, MD, USA |
| 43 | Vaccine Protection against Functional Cytotoxic T Lymphocyte Abnormalities in Simian Human Immunodeficiency Virus-Infected Rhesus Monkeys
P. F. McKay*, J. E. Schmitz, M. J. Kuroda, D. H. Barouch, M. A. Lifton, C. E. Nickerson, D. A. Gorgone, and N. L. Letvin Beth Israel Deaconess Med. Ctr., Harvard Med. Sch., Boston, MA, USA |
| 44 | Working toward an AIDS Vaccine
H. L. Robinson Emory Vaccine Ctr. and Yerkes Primate Res. Ctr., Atlanta, GA, USA |